Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$243.46
+0.00%
Mkt Cap $14.73B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (43 analysts)
$287.50
Range $250.00 – $345.00
Implied Upside
+18.1%
Consensus $287.50 vs current $243.46
NASDAQ·Healthcare·Biotechnology
$243.46
+0.00%
Mkt Cap $14.73B
Buy
8
Hold
0
Sell
0
Price Target (43 analysts)
$287.50
Range $250.00 – $345.00
+18.1%
Consensus $287.50 vs current $243.46